These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26327604)

  • 81. Current progress and potential practical application for human pluripotent stem cells.
    Philonenko ES; Shutova MV; Chestkov IV; Lagarkova MA; Kiselev SL
    Int Rev Cell Mol Biol; 2011; 292():153-96. PubMed ID: 22078961
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Quantifying signaling pathway activation to monitor the quality of induced pluripotent stem cells.
    Makarev E; Fortney K; Litovchenko M; Braunewell KH; Zhavoronkov A; Atala A
    Oncotarget; 2015 Sep; 6(27):23204-12. PubMed ID: 26327604
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Transcriptome Profiling Reveals Degree of Variability in Induced Pluripotent Stem Cell Lines: Impact for Human Disease Modeling.
    Schuster J; Halvardson J; Pilar Lorenzo L; Ameur A; Sobol M; Raykova D; Annerén G; Feuk L; Dahl N
    Cell Reprogram; 2015 Oct; 17(5):327-37. PubMed ID: 26348590
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
    Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
    Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Directed neuronal differentiation of mouse embryonic and induced pluripotent stem cells and their gene expression profiles.
    Chen X; Gu Q; Wang X; Ma Q; Tang H; Yan X; Guo X; Yan H; Hao J; Zeng F
    Int J Mol Med; 2013 Jul; 32(1):25-34. PubMed ID: 23652807
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Identification of the early and late responder genes during the generation of induced pluripotent stem cells from mouse fibroblasts.
    Park J; Kwon YW; Ham S; Hong CP; Seo S; Choe MK; Shin SI; Lee CS; Kim HS; Roh TY
    PLoS One; 2017; 12(2):e0171300. PubMed ID: 28152015
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pathway activation strength is a novel independent prognostic biomarker for cetuximab sensitivity in colorectal cancer patients.
    Zhu Q; Izumchenko E; Aliper AM; Makarev E; Paz K; Buzdin AA; Zhavoronkov AA; Sidransky D
    Hum Genome Var; 2015; 2():15009. PubMed ID: 27081524
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The OncoFinder algorithm for minimizing the errors introduced by the high-throughput methods of transcriptome analysis.
    Buzdin AA; Zhavoronkov AA; Korzinkin MB; Roumiantsev SA; Aliper AM; Venkova LS; Smirnov PY; Borisov NM
    Front Mol Biosci; 2014; 1():8. PubMed ID: 25988149
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Methods of induced pluripotent stem cells for clinical application.
    Seki T; Fukuda K
    World J Stem Cells; 2015 Jan; 7(1):116-25. PubMed ID: 25621111
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cells.
    Aliper AM; Csoka AB; Buzdin A; Jetka T; Roumiantsev S; Moskalev A; Zhavoronkov A
    Aging (Albany NY); 2015 Jan; 7(1):26-37. PubMed ID: 25587796
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Pathway activation profiling reveals new insights into age-related macular degeneration and provides avenues for therapeutic interventions.
    Makarev E; Cantor C; Zhavoronkov A; Buzdin A; Aliper A; Csoka AB
    Aging (Albany NY); 2014 Dec; 6(12):1064-75. PubMed ID: 25543336
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Signaling pathways activation profiles make better markers of cancer than expression of individual genes.
    Borisov NM; Terekhanova NV; Aliper AM; Venkova LS; Smirnov PY; Roumiantsev S; Korzinkin MB; Zhavoronkov AA; Buzdin AA
    Oncotarget; 2014 Oct; 5(20):10198-205. PubMed ID: 25415353
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Novel robust biomarkers for human bladder cancer based on activation of intracellular signaling pathways.
    Lezhnina K; Kovalchuk O; Zhavoronkov AA; Korzinkin MB; Zabolotneva AA; Shegay PV; Sokov DG; Gaifullin NM; Rusakov IG; Aliper AM; Roumiantsev SA; Alekseev BY; Borisov NM; Buzdin AA
    Oncotarget; 2014 Oct; 5(19):9022-32. PubMed ID: 25296972
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Oncofinder, a new method for the analysis of intracellular signaling pathway activation using transcriptomic data.
    Buzdin AA; Zhavoronkov AA; Korzinkin MB; Venkova LS; Zenin AA; Smirnov PY; Borisov NM
    Front Genet; 2014; 5():55. PubMed ID: 24723936
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application.
    Kamao H; Mandai M; Okamoto S; Sakai N; Suga A; Sugita S; Kiryu J; Takahashi M
    Stem Cell Reports; 2014 Feb; 2(2):205-18. PubMed ID: 24527394
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Comparison of the molecular profiles of human embryonic and induced pluripotent stem cells of isogenic origin.
    Mallon BS; Hamilton RS; Kozhich OA; Johnson KR; Fann YC; Rao MS; Robey PG
    Stem Cell Res; 2014 Mar; 12(2):376-86. PubMed ID: 24374290
    [TBL] [Abstract][Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.